GTHX G1 Therapeutics Inc
5,069
$4.13
$0.14
(3.28%)
| Watchers | 5,069 |
| 52-Wk Low | $1.08 |
| 52-Wk High | $5.00 |
| Market Cap | $223.24M |
| Volume | 45,407.00 |
| 52-Wk High | $5.00 |
| 52-Wk Low | $1.08 |
Evaluating G1 Therapeutics: Insights From 5 Financial AnalystsBenzinga • 6 days ago
Latest Ratings for GTHX
DateFirmActionFromTo Nov 2021JP MorganDowngradesNeutralUnderweight Nov 2021HC Wainwright & Co.MaintainsBuy Nov 2021Raymond JamesMaintainsOutperform
View More Analyst...
Share to Feed
Biotech Innovations Paving the Way in Breast Cancer Fight Biotech Innovations Paving the Way in Breast Cancer Fight PR Newswire VANCOUVER, BC, April 11, 2024 FN Media Group Presents USA News Group...
G1 Therapeutics (NASDAQ:GTHX - Get Free Report) and NLS Pharmaceutics (NASDAQ:NLSP - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two...
RESEARCH TRIANGLE PARK, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1's Chief Executive Officer Jack...
This is a signal that GTHX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
G1 Therapeutics, Inc. (NASDAQ:GTHX - Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 2,690,000 shares, a drop of 7.6% from the...
RESEARCH TRIANGLE PARK, N.C., April 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options...
This is a signal that GTHX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that GTHX's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This price move could be a signal that GTHX may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...